ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.340,57
0,65%
S&P 500
5.943,70
-0,53%
Dow Jones
42.694,39
-0,03%
Euro vs US Dollar
1,03626
-0,20%
Bitcoin
97.269,19
-4,91%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC

  6. Daiichi Sankyo Co Ltd (PK) (DSKYF) Börsenkurse

Daiichi Sankyo Co Ltd (PK)

Daiichi Sankyo Co Ltd (PK) (DSKYF)

USOTC
26,20
-2,64
( -9,15% )
Aktualisiert: 18:52:52
Verzögert um 15 Minuten

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
26,20
Gebot
25,80
Fragen
28,75
Volumen
19.108
25,80 Tagesbereich 28,84
25,45 52-Wochen-Bereich 44,64
Marktkapitalisierung
50,22B
Handelsende
28,84
Handelsbeginn
25,96
Letzte Trade
55
@
26.2
Letzter Handelszeitpunkt
19:08:52
Finanzvolumen
US$ 503.720
VWAP
26,3617
Durchschnittliches Volumen (3 Mio.)
13.059
Ausgegebene Aktien
1.916.787.029
Dividendenrendite
18,059.43%
Kurs-Gewinn-Verhältnis
0,28
Gewinn pro Aktie (EPS)
104,72
Erlöse
1,63T
Nettogewinn
200,73B

Über Daiichi Sankyo Co Ltd (PK)

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Biolog/vaccines
Website
www.daiichisankyo.co.jp
Hauptsitz
Chuo, Tokyo, Jpn
Gegründet
2005
Daiichi Sankyo Co Ltd (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker DSKYF. The last closing price for Daiichi Sankyo (PK) was US$28,84. Over the last year, Daiichi Sankyo (PK) shares have traded in a share price range of US$ 25,45 to US$ 44,64.

Daiichi Sankyo (PK) currently has 1.916.787.029 shares in issue. The market capitalisation of Daiichi Sankyo (PK) is US$55,28 billion. Daiichi Sankyo (PK) has a price to earnings ratio (PE ratio) of 0.28.

DSKYF Neueste Nachrichten

Weitere Nachrichten

Daiichi Sankyo's Once-Daily Lixiana® (edoxaban) Approved for the Prevention of Stroke and Systemic Embolism in Non-Valvular ...

Daiichi Sankyo's Once-Daily Lixiana® (edoxaban) Approved for the Prevention of Stroke and Systemic Embolism in Non-Valvular Atrial Fibrillation and for the Treatment and Prevention of Recurrent...

15 April 2015
PR Newswire (US)

Daiichi Sankyo, Inc. and Asubio Pharmaceuticals, Inc. Merge

Daiichi Sankyo, Inc. and Asubio Pharmaceuticals, Inc. Merge PR Newswire PARSIPPANY, N.J., April 1, 2015 PARSIPPANY, N.J., April 1, 2015 /PRNewswire/ -- Daiichi Sankyo, Inc., the US subsidiary of...

01 April 2015
PR Newswire (US)

Daiichi Sankyo, Inc. Names Danesha Dixon Smith Vice President of Human Resources

Daiichi Sankyo, Inc. Names Danesha Dixon Smith Vice President of Human Resources PR Newswire PARSIPPANY, N.J., June 28, 2011 PARSIPPANY, N.J., June 28, 2011 /PRNewswire/ -- Daiichi Sankyo, Inc...

28 Juni 2011
PR Newswire (US)

John P. Gargiulo Named President and CEO of Daiichi Sankyo, Inc.

John P. Gargiulo Named President and CEO of Daiichi Sankyo, Inc. PR Newswire PARSIPPANY, N.J., April 4, 2011 PARSIPPANY, N.J., April 4, 2011 /PRNewswire/ -- Daiichi Sankyo, Inc. (DSI) announced...

04 April 2011
PR Newswire (US)

Update: Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fib

Update: Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fibrillation - More Than 21,000 Patients Enrolled in the Largest...

01 Dezember 2010
PR Newswire (US)

Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fibrillatio

Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fibrillation - More Than 21,000 Patients Enrolled in the Largest Clinical...

01 Dezember 2010
PR Newswire (US)

ArQule and Daiichi Sankyo Expand Drug Discovery Collaboration in Oncology

ArQule and Daiichi Sankyo Expand Drug Discovery Collaboration in Oncology PR Newswire WOBURN, Massachusetts, October 12, 2010 WOBURN, Massachusetts, October 12, 2010 /PRNewswire/ -- ArQule, Inc...

12 Oktober 2010
PR Newswire (US)

Patients with Hypertension at Risk Due to Physician Inertia

Patients with Hypertension at Risk Due to Physician Inertia - New Supporting Hypertension Awareness and Research Europe-wide (SHARE) Survey Reports Findings at the 20th Annual Society of the...

21 Juni 2010
PR Newswire (US)

Daiichi Sankyo Submits First New Drug Application for Oral Factor Xa Inhibitor, Edoxaban

Daiichi Sankyo Submits First New Drug Application for Oral Factor Xa Inhibitor, Edoxaban - Innovative Once-Daily Oral Factor Xa Inhibitor Submitted for Approval in Japan PR Newswire TOKYO, April...

06 April 2010
PR Newswire (US)

Daiichi Sankyo, Inc. Names Dr. Jay Feingold Vice President, Medical Affairs

Bolsters Company's Expertise in Areas of Oncology and Hematology PARSIPPANY, N.J., Feb. 11 /PRNewswire-FirstCall/ -- Daiichi Sankyo, Inc. (DSI) announced today that Jay M. Feingold, M.D., Ph.D...

11 Februar 2010
PR Newswire (US)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.040.15290519877726.1629.825.5868127.00644481CS
4-1.66-5.958363244827.8631.4925.452960727.36631163CS
12-5.6-17.610062893131.834.7525.451305928.3138921CS
26-10.93-29.437112846837.1344.6425.45726830.02599905CS
52-2.63-9.122441900828.8344.6425.451200031.11070826CS
1563.3514.660831509822.8544.6419.45862330.09620244CS
260-39.25-59.969442322465.4595.9617.61665229.83932349CS

DSKYF - Frequently Asked Questions (FAQ)

What is the current Daiichi Sankyo (PK) share price?
The current share price of Daiichi Sankyo (PK) is US$ 26,20
How many Daiichi Sankyo (PK) shares are in issue?
Daiichi Sankyo (PK) has 1.916.787.029 shares in issue
What is the market cap of Daiichi Sankyo (PK)?
The market capitalisation of Daiichi Sankyo (PK) is USD 55,28B
What is the 1 year trading range for Daiichi Sankyo (PK) share price?
Daiichi Sankyo (PK) has traded in the range of US$ 25,45 to US$ 44,64 during the past year
What is the PE ratio of Daiichi Sankyo (PK)?
The price to earnings ratio of Daiichi Sankyo (PK) is 0,28
What is the cash to sales ratio of Daiichi Sankyo (PK)?
The cash to sales ratio of Daiichi Sankyo (PK) is 0,03
What is the reporting currency for Daiichi Sankyo (PK)?
Daiichi Sankyo (PK) reports financial results in JPY
What is the latest annual turnover for Daiichi Sankyo (PK)?
The latest annual turnover of Daiichi Sankyo (PK) is JPY 1,63T
What is the latest annual profit for Daiichi Sankyo (PK)?
The latest annual profit of Daiichi Sankyo (PK) is JPY 200,73B
What is the registered address of Daiichi Sankyo (PK)?
The registered address for Daiichi Sankyo (PK) is 3-5-1 NIHONBASHI-HONCHO, CHUO-KU, CHUO, TOKYO, 103-8426
What is the Daiichi Sankyo (PK) website address?
The website address for Daiichi Sankyo (PK) is www.daiichisankyo.co.jp
Which industry sector does Daiichi Sankyo (PK) operate in?
Daiichi Sankyo (PK) operates in the PHARMACEUTICAL BIOLOG/VACCINES sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
AAGRAfrican Agriculture Holdings Inc (CE)
US$ 0,008
(799.900,00%)
477
PLFXPulse Evolution Corporation (CE)
US$ 0,0003
(29.900,00%)
530
EATREastern Asteria Inc (CE)
US$ 0,0003
(29.900,00%)
3,59M
ZAAGZA Group Inc (PK)
US$ 0,0001
(9.900,00%)
50k
RBSHRebus Holdings Inc (CE)
US$ 0,0001
(9.900,00%)
402
FPWMCharlestowne Premium Beverages Inc (CE)
US$ 0,000001
(-100,00%)
1.000
CRGPCalissio Resources Group Inc (CE)
US$ 0,000001
(-99,75%)
28k
NEOMNeoMedia Technologies Inc (CE)
US$ 0,000001
(-99,50%)
736
NOXLNoxel Corp (CE)
US$ 0,000001
(-99,00%)
59,9k
TMGIMarquie Group Inc (PK)
US$ 0,000001
(-99,00%)
4,53M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0,0037
(-19,57%)
246,99M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0,0001
(-50,00%)
243,57M
ASIIAccredited Solutions Inc (PK)
US$ 0,0006
(20,00%)
169,13M
NSAVNet Savings Link Inc (PK)
US$ 0,0004
(-20,00%)
161,2M
TKMOTekumo Inc (PK)
US$ 0,00025
(-16,67%)
145,76M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

USOTC
DSKYF
Daiichi Sankyo (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten